<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02757573</url>
  </required_header>
  <id_info>
    <org_study_id>R16005</org_study_id>
    <nct_id>NCT02757573</nct_id>
  </id_info>
  <brief_title>The Right Ventricular Responses to Mild Hypercarbia After Mitral Valve Repair Surgery</brief_title>
  <official_title>The Right Ventricular Responses to Mild Hypercarbia After Mitral Valve Repair Surgery - Assessment With Pulmonary Arterial Catheter and Transesophageal Echocardiography Measurements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of the study is to investigate the right ventricular responses to mild hypercarbia&#xD;
      after mitral valve prolapse repair surgery by the measurements obtained on pulmonary arterial&#xD;
      catheter and transesophageal echocardiography.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aims of the study is to investigate the right ventricular responses to mild hypercarbia&#xD;
      after mitral valve prolapse repair surgery by the measurements obtained on pulmonary arterial&#xD;
      catheter and transesophageal echocardiography. Investigators hypothesize that induced mild&#xD;
      hypercarbia (PaCO2 7.5 kPa) cause elevated mean pulmonary arterial pressure and pulmonary&#xD;
      vascular resistance, and this reflect to the right ventricle, both volume and function. And&#xD;
      this right ventricle effect could be noticed by echocardiography.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tricuspid annular plane systolic excursion (TAPSE)</measure>
    <time_frame>Change from baseline TAPSE at hypercarbia (in approximately 30 min)</time_frame>
    <description>TAPSE will be measured at baseline (PaCO2 5 kPa) and at hypercarbia (PaCO2 7.5 kPa)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean pulmonary artery pressure (MPAP)</measure>
    <time_frame>Change from baseline MPAP at hypercarbia (in approximately 30 min)</time_frame>
    <description>MPAP will be measured at baseline (PaCO2 5 kPa) and at hypercarbia (PaCO2 7.5 kPa)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Heart; Decompensation, Right Ventricle</condition>
  <condition>Echocardiography</condition>
  <condition>Hypercapnia</condition>
  <arm_group>
    <arm_group_label>Hypercarbia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hypercarbia: PaCO2 is elevated from 5 to 7.5 kPa by controlled ventilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hypercarbia</intervention_name>
    <description>PaCO2 is elevated from 5 to 7.5 kPa by controlled ventilation.</description>
    <arm_group_label>Hypercarbia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  scheduled mitral valve prolapse repair surgery&#xD;
&#xD;
          -  able to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  preoperative right ventricular dysfunction or pulmonary hypertension&#xD;
&#xD;
          -  significant tricuspid regurgitation&#xD;
&#xD;
          -  congenital heart defect&#xD;
&#xD;
          -  ventricular dyssynchrony or wide QRS-complex on ECG (&gt; 130 ms)&#xD;
&#xD;
          -  prior myocardial infarction (within tree months) or pericardial constriction&#xD;
&#xD;
          -  preoperative left ventricular (LV) dysfunction, i.e. LV ejection fraction under 40 %&#xD;
&#xD;
          -  if the scheduled repair by plastic procedure has been converted to mitral valve&#xD;
             replacement&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kati J채rvel채, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kati Rautaneva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tampere University Hospital Heart Center</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 20, 2016</study_first_submitted>
  <study_first_submitted_qc>April 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2016</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Kati J채rvel채</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

